The Relationship Between Body Mass Index and In-Hospital Mortality in the Contemporary Era of an Acute Myocardial Infarction Management

References

• Muller MJ, Braun W, Enderle J, Bosy-Westphal A. Beyond BMI: conceptual issues related to overweight and obese patients. Obes Facts. 2016;9:193–205. doi:10.1159/000445380
   PubMedGoogle Scholar
• World Health Organization. Body mass index - BMI. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. Accessed July 2020.
   Google Scholar
• Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280–287. doi:10.1001/jamacardio.2018.0022
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–1932. doi:10.1016/j.jacc.2008.12.068
   PubMed Web of Science ®Google Scholar
• Das SR, Alexander KP, Chen AY. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011;58:2642–2650. doi:10.1016/j.jacc.2011.09.030
   PubMed Web of Science ®Google Scholar
• Global BMIMC, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776–786. doi:10.1016/S0140-6736(16)30175-1
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Das SR, Simon DN, Diercks DB, Alexander KP. The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR. Eur Heart J Qual Care Clin Outcomes. 2017;3:183–191. doi:10.1093/ehjqcco/qcx010
   PubMed Web of Science ®Google Scholar
• Kadakia MB, Fox CS, Scirica BM, Murphy SA. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart. 2011;97:1782–1787. doi:10.1136/heartjnl-2011-300231
   PubMed Web of Science ®Google Scholar
• Buettner HJ, Mueller C, Gick M, et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J. 2007;28:1694–1701. doi:10.1093/eurheartj/ehm220
   PubMed Web of Science ®Google Scholar
• Diercks DB, Roe MT, Mulgund J. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J. 2006;152:140–148.
   PubMed Web of Science ®Google Scholar
• Mahaffey KW, Tonev ST, Spinler SA, et al. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol. 2010;139:123–133. doi:10.1016/j.ijcard.2008.10.008
   PubMed Web of Science ®Google Scholar
• Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863–870. doi:10.1016/j.amjmed.2007.05.011
   PubMed Web of Science ®Google Scholar
• Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006;110:153–159. doi:10.1016/j.ijcard.2005.06.040
   PubMed Web of Science ®Google Scholar
• Eisenstein EL, McGuire DK, Bhapkar MV, et al. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med. 2005;118:981–990. doi:10.1016/j.amjmed.2005.02.017
   PubMedGoogle Scholar
• Lamelas P, Schwalm JD, Quazi I, Mehta S, Devereaux PJ. Effect of body mass index on clinical events after acute coronary syndromes. Am J Cardiol. 2017;120:1453–1459. doi:10.1016/j.amjcard.2017.07.043
   PubMedGoogle Scholar
• Elbaz-Greener G, Rozen G, Kusniec F, et al. Trends in utilization and safety of in-hospital coronary artery bypass grafting during a non-ST-segment elevation myocardial infarction. Am J Cardiol. 2020;134:32–40. doi:10.1016/j.amjcard.2020.08.019
   PubMedGoogle Scholar
• Healthcare Cost and Utilization Project (HCUP). 2000–2011. Agency for Healthcare Research and Quality R, MD. Available from: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 2020.
   Google Scholar
• HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2012–2013. Agency for Healthcare Research and Quality R, MD. Available from: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 2020.
   Google Scholar
• Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract. 2002;5:143–151.
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol Ma. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619. doi:10.1016/0895-4356(92)90133-8
   PubMed Web of Science ®Google Scholar
• Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res. 2010;10:140. doi:10.1186/1472-6963-10-140
   PubMed Web of Science ®Google Scholar
• Radovanovic D, Seifert B, Urban P, et al. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012. Heart. 2014;100:288–294. doi:10.1136/heartjnl-2013-304588
   PubMed Web of Science ®Google Scholar
• Hosseini SM, Moazzami K, Rozen G, Vaid J, Saleh A, Heist KE. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013. Eur Heart J. 2017;38:2122–2128. doi:10.1093/eurheartj/ehx100
   PubMedGoogle Scholar
• Angeras O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013;34:345–353. doi:10.1093/eurheartj/ehs217
   PubMed Web of Science ®Google Scholar
• Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol. 2005;98:123–131. doi:10.1016/j.ijcard.2004.03.042
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Valente S, Chiostri M, et al. Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. NMCD. 2012;23:205–211.
   PubMed Web of Science ®Google Scholar
• Niedziela J, Hudzik B, Niedziela N, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801–812. doi:10.1007/s10654-014-9961-9
   PubMed Web of Science ®Google Scholar
• Aronson D, Nassar M, Goldberg T, Kapeliovich M. The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol. 2010;145:476–480. doi:10.1016/j.ijcard.2009.12.029
   PubMedGoogle Scholar
• Lopez-Jimenez F, Jacobsen SJ, Reeder GS, Weston SA. Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community. Chest. 2004;125:1205–1212. doi:10.1378/chest.125.4.1205
   PubMed Web of Science ®Google Scholar
• Mehta L, Devlin W, McCullough PA, O’Neill WW, Skelding KA, Stone GW. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99:906–910. doi:10.1016/j.amjcard.2006.11.038
   PubMedGoogle Scholar
• Mehta RH, Gitt AK, Junger C, et al. Body mass index and effectiveness of reperfusion strategies: implications for the management of patients with ST-elevation myocardial infarction. J Interv Cardiol. 2008;21:8–14. doi:10.1111/j.1540-8183.2007.00311.x
   PubMed Web of Science ®Google Scholar
• Oliveros H, Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring). 2008;16:515–521. doi:10.1038/oby.2007.102
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433–442. doi:10.1097/MCO.0b013e3281a30594
   PubMed Web of Science ®Google Scholar
• Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol. 2006;98:944–948. doi:10.1016/j.amjcard.2006.04.039
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circ. 2007;116:627–636. doi:10.1161/CIRCULATIONAHA.106.679779
   PubMed Web of Science ®Google Scholar
• Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J. 2000;21:521–532. doi:10.1053/euhj.1999.1882
   PubMedGoogle Scholar
• Coats A, Anker SD, Roecker EB, et al. Prevention and reversal of cardiac cachexia in patients with severe heart failure by carvedilol: results of the COPERNICUS study. Circulation. 2001;10:4II–437.
   Google Scholar